Liposomes for Magnetic Resonance Image-Guided Drug Delivery; Lipid Chain Length Affects Drug Release and MRI...

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Radiology

Background:

• Image-guided drug delivery enhances therapeutic precision by tracking drug carriers.
• Magnetic Resonance Imaging (MRI)-guided systems are promising for targeted drug release in tumors.
• Liposomes are effective drug carriers that can be labeled for MRI tracking.

Purpose of the Study:

• To synthesize and characterize novel lipids conjugated to Gd-DOTA for MRI-guided liposomal drug delivery.
• To investigate the impact of varying lipid ratios on liposome properties, including thermal stability and MRI relaxivity.
• To assess the potential for MRI-based confirmation of drug release from these liposomes.

Main Methods:

• Synthesis of two Gd-DOTA conjugated lipids (C18-LCA-1 and C16-LCA-2).
• Incorporation of lipids into liposomes at different ratios.
• Differential Scanning Calorimetry (DSC) to determine liposome phase transition temperature (Tm).
• Nuclear Magnetic Resonance (NMR) to measure relaxivity.

Main Results:

• The ratio of LCA-1 and LCA-2 lipids in liposomes significantly influenced liposome Tm and relaxivity.
• Lipid composition affected thermal drug release characteristics.
• Introduced lipids conferred MRI tracking capabilities to liposomes.

Conclusions:

• Liposomes incorporating LCA-1 and LCA-2 lipids offer tunable thermal release and MRI relaxivity.
• The developed liposomes enable MRI-based tracking and confirmation of drug release.
• This approach holds potential for image-guided, targeted cancer therapy using MRI at clinical field strengths.